NEW YORK (GenomeWeb News) – Nanogen today said that it will collaborate with Italian firm A. Menarini Diagnostics to sell CE-marked in vitro diagnostic kits based on Nanogen’s MGB technology for infectious diseases.
 
Nanogen will manufacture the kits, which will be branded as Menarini products and sold by the Italian firm in Europe. The San Diego-based firm did not disclose which infectious diseases the molecular diagnostic test kits will target, but it said products would be introduced to the market in 2009.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.